ASKP1240 in De Novo Kidney Transplant Recipients

Trial Profile

ASKP1240 in De Novo Kidney Transplant Recipients

Phase of Trial: Phase III

Latest Information Update: 10 Aug 2015

At a glance

  • Drugs Bleselumab (Primary) ; Mycophenolate mofetil; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 10 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top